Marken acquires three European firms, assessing additional deals: ‘Stay tuned,’ says CEO

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Shutter_m)
(Image: Getty/Shutter_m)

Related tags Marken Logistics Europe Clinical development

Marken has purchased three European logistics firms and is assessing additional locations at which the CEO said it plans to either build or buy.

Marken’s acquisition of Italy-based HRTL as well as HETO and Der Kurier in Austria and Hungary, respectively, increases the company’s site network to 51, including 10 good manufacturing practice (GMP) qualified clinical storage depots. 

Marken CEO Wes Wheeler said the acquisitions make “good business sense”​ for the company given the large number of shipments exported from Italy, Hungary, and Austria. “Italy is a particularly important market for outbound services given the high concentration of sterile drugs produced in that country,”​ he told us.

Marken will offer its hybrid services​ – which uses UPS' network and airline – to and from gateway airports in Rome, Milan, Vienna, and Budapest.

The acquisition will see the addition of 30 new employees dedicated to clinical logistics. This also will further expand Marken’s direct to/from patient operations to these countries, giving the company more direct control of the drivers calling on patient’s homes. 

As for future acquisition plans, Wheeler said the company is “always looking to strengthen its network around the world.”

“We analyze data sources to determine where the patients are being recruited from and then assess if it makes good business sense to have a direct operation there,” ​he explained.

Marken is currently in the process of assessing an additional three to four locations at which it plans to either build or buy. Said Wheeler, “Stay tuned for further announcements.”

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us

Products

View more

Webinars